UNSPSC 51362505: Iminophenimide

This classification denotes a sedative and hypnotic with the molecular formula C12H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H0X939RX9W, chemically known as 3-ethyl-3-phenyl-2,6-piperazindion but generally known as iminophenimide, which bears US NIH Compound Identifier 163317. European Medicines Agency schedules Iminophenimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08150MIG.

UNSPSC 51362505 Iminophenimide, a Commodity code, does not align with the state and local procurement activity tagged under it. The single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS, which solicits naloxone and safe drug deactivation systems for community health initiatives—products unrelated to the chemical compound named in the code. The mismatch suggests either a coding error in the county's procurement system or a divergence between the code's nominal scope and actual purchasing practice in this jurisdiction.

Seminole County posted the IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023—a date that predates the posting by nearly three years, indicating a data quality issue in the source record. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify compliance, and potential FEMA funding. No recent opportunities beyond this single record appear in the available data, suggesting the code receives minimal or sporadic state and local procurement activity.